SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-023553
Filing Date
2022-06-17
Accepted
2022-06-17 16:05:29
Documents
12
Period of Report
2022-06-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-8k_20220617.htm   iXBRL 8-K 39294
  Complete submission text file 0001564590-22-023553.txt   167439

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hsto-20220617.xsd EX-101.SCH 5601
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20220617_lab.xml EX-101.LAB 19324
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20220617_pre.xml EX-101.PRE 11495
6 EXTRACTED XBRL INSTANCE DOCUMENT hsto-8k_20220617_htm.xml XML 3547
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 221023754
SIC: 2834 Pharmaceutical Preparations